GlobeNewswire Inc.··American Urological AssociationDurvalumab Combo Shows Promise in Bladder Cancer; Environmental Risks Emerge
New research reveals immunotherapy durvalumab delays bladder cancer progression when combined with BCG, while air pollution and e-cigarettes emerge as risk factors.
AZNbladder cancerimmunotherapy